Home/ Stocks/ MCRB

Seres Therapeutics, Inc.

MCRB XNAS

$4.87 -0.12 (-2.49%) ▼ 15-min delayed

Open

$5.07

High

$5.19

Low

$4.82

Volume

62.3K

Market Cap

$47.92M

About Seres Therapeutics, Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 66 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$736.0K	$4.58M	$0.47
Q1 2026	$358.0K	$-19,913,000	$-2.08
FY 2025	$789.0K	$5.70M	$0.64
Q3 2025	$351.0K	$8.20M	$0.94

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for MCRB yet. Check out our latest market news or earnings calendar.

Get MCRB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Seres Therapeutics, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.